+Vote!
Medical News Today (Free subscription) | 08/21/2008
The Institute of Cancer Research's scientist, Dr Gerhardt Attard has just been awarded a Young Investigator Award by the Prostate Cancer Foundation (PCF) for his ongoing work into developing the prostate cancer drug abiraterone. Designed to encourage the most innovative research thinkers to continue their careers in prostate cancer research, the awards provide recipients with $75,000...
+Vote!
The Herald (Free subscription) | 07/22/2008
... prostate tumours can generate hormones of their own when the normal supply is cut off.Dr Gerhardt Attard, one of the scientists from the Institute of Cancer Research in Sutton, Surrey, where the drug was discovered, said: "Time will be our judge, but we're very excited about this. It is changing our understanding of prostate cancer in a way that has not been done for 50 or 60 years."The...
+Vote!
Liverpool Echo.co.uk (Free subscription) | 07/22/2008
Dr Gerhardt Attard, one of the scientists from the Institute of Cancer Research in Sutton, Surrey, where the drug was discovered, said: "Time will be our judge, but we're very excited about this. It is changing our understanding of prostate cancer in a way that has not been done for 50 or 60 years."
+Vote!
icWales (Free subscription) | 07/22/2008
Dr Gerhardt Attard, one of the scientists from the Institute of Cancer Research in Sutton, Surrey, where the drug was discovered, said: "Time will be our judge, but we're very excited about this. It is changing our understanding of prostate cancer in a way that has not been done for 50 or 60 years."
+Vote!
Liverpool Daily Post.co.uk (Free subscription) | 07/22/2008
Dr Gerhardt Attard, one of the scientists from the Institute of Cancer Research in Sutton, Surrey, where the drug was discovered, said: "Time will be our judge, but we're very excited about this. It is changing our understanding of prostate cancer in a way that has not been done for 50 or 60 years."
